191 related articles for article (PubMed ID: 24865150)
1. Targeting the α7 nicotinic acetylcholine receptor to prevent progressive dementia and improve cognition in adults with Down's syndrome.
Deutsch SI; Burket JA; Benson AD
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():131-9. PubMed ID: 24865150
[TBL] [Abstract][Full Text] [Related]
2. The α7 nicotinic acetylcholine receptor: A mediator of pathogenesis and therapeutic target in autism spectrum disorders and Down syndrome.
Deutsch SI; Burket JA; Urbano MR; Benson AD
Biochem Pharmacol; 2015 Oct; 97(4):363-377. PubMed ID: 26074265
[TBL] [Abstract][Full Text] [Related]
3. Progressive worsening of adaptive functions in Down syndrome may be mediated by the complexing of soluble Abeta peptides with the alpha 7 nicotinic acetylcholine receptor: therapeutic implications.
Deutsch SI; Rosse RB; Mastropaolo J; Chilton M
Clin Neuropharmacol; 2003; 26(5):277-83. PubMed ID: 14520169
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor-mediated amyloid-β uptake in SH-SY5Y cells.
Yang WN; Ma KG; Chen XL; Shi LL; Bu G; Hu XD; Han H; Liu Y; Qian YH
Neuroscience; 2014 Oct; 278():276-90. PubMed ID: 25168732
[TBL] [Abstract][Full Text] [Related]
5. The p38 mitogen activated protein kinase regulates β-amyloid protein internalization through the α7 nicotinic acetylcholine receptor in mouse brain.
Ma KG; Lv J; Yang WN; Chang KW; Hu XD; Shi LL; Zhai WY; Zong HF; Qian YH
Brain Res Bull; 2018 Mar; 137():41-52. PubMed ID: 29128415
[TBL] [Abstract][Full Text] [Related]
6. Galantamine Inhibits Aβ
Lin MW; Chen YH; Yang HB; Lin CC; Hung SY
Neurotherapeutics; 2020 Apr; 17(2):676-689. PubMed ID: 31823156
[TBL] [Abstract][Full Text] [Related]
7. Increased Aβ
Wang HY; Trocmé-Thibierge C; Stucky A; Shah SM; Kvasic J; Khan A; Morain P; Guignot I; Bouguen E; Deschet K; Pueyo M; Mocaer E; Ousset PJ; Vellas B; Kiyasova V
Alzheimers Res Ther; 2017 Jul; 9(1):54. PubMed ID: 28750690
[TBL] [Abstract][Full Text] [Related]
8. Effect of beta-amyloid peptide 1-42 on the cytoprotective action mediated by alpha7 nicotinic acetylcholine receptors in growth factor-deprived differentiated PC-12 cells.
Li XD; Buccafusco JJ
J Pharmacol Exp Ther; 2003 Nov; 307(2):670-5. PubMed ID: 12970390
[TBL] [Abstract][Full Text] [Related]
9. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
D'Andrea MR; Nagele RG
Curr Pharm Des; 2006; 12(6):677-84. PubMed ID: 16472157
[TBL] [Abstract][Full Text] [Related]
10. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the MAPKs pathways affects Aβ-induced cognitive deficits in Alzheimer's disease via activation of α7nAChR.
Chang KW; Zong HF; Rizvi MY; Ma KG; Zhai W; Wang M; Yang WN; Ji SF; Qian YH
Neurobiol Learn Mem; 2020 Feb; 168():107154. PubMed ID: 31904546
[TBL] [Abstract][Full Text] [Related]
12. Activation of α7 nicotinic acetylcholine receptor alleviates Aβ
Chang KW; Zong HF; Ma KG; Zhai WY; Yang WN; Hu XD; Xu JH; Chen XL; Ji SF; Qian YH
Neurochem Int; 2018 Nov; 120():238-250. PubMed ID: 30217465
[TBL] [Abstract][Full Text] [Related]
13. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology.
Wang HY; Lee DH; D'Andrea MR; Peterson PA; Shank RP; Reitz AB
J Biol Chem; 2000 Feb; 275(8):5626-32. PubMed ID: 10681545
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β peptide increases cell surface localization of α7 ACh receptor to protect neurons from amyloid β-induced damage.
Jin Y; Tsuchiya A; Kanno T; Nishizaki T
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):157-60. PubMed ID: 26522221
[TBL] [Abstract][Full Text] [Related]
15. Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease.
Singh S; Agrawal N; Goyal A
CNS Neurol Disord Drug Targets; 2024; 23(3):384-394. PubMed ID: 37366362
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of oligomeric amyloid β peptide binding to α7 nicotinic receptor.
Cecon E; Dam J; Luka M; Gautier C; Chollet AM; Delagrange P; Danober L; Jockers R
Br J Pharmacol; 2019 Sep; 176(18):3475-3488. PubMed ID: 30981214
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase signaling pathways promote low-density lipoprotein receptor-related protein 1-mediated internalization of beta-amyloid protein in primary cortical neurons.
Yang WN; Ma KG; Qian YH; Zhang JS; Feng GF; Shi LL; Zhang ZC; Liu ZH
Int J Biochem Cell Biol; 2015 Jul; 64():252-64. PubMed ID: 25936756
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
19. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
[TBL] [Abstract][Full Text] [Related]
20. Localization of α7 nicotinic acetylcholine receptor immunoreactivity on GABAergic interneurons in layers I-III of the rat retrosplenial granular cortex.
Murakami K; Ishikawa Y; Sato F
Neuroscience; 2013 Nov; 252():443-59. PubMed ID: 23985568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
